The Psychedelic Drug Trial has exclusive access to a ground-breaking new trial at Imperial College London. The trial sees, for the first time ever under controlled conditions, a psychedelic drug tested head-to-head against a standard antidepressant as a treatment for depression. The film follows a pioneering team of scientists and psychotherapists, led by Professor David Nutt, Dr Robin Carhart-Harris and Dr Rosalind Watts, as they compare the effects of psilocybin (the active ingredient of magic mushrooms) with an antidepressant (an SSRI called escitalopram) on a small group of participants with clinical depression. This is scientific research at its most cutting edge. With over seven million people being prescribed antidepressants each year in England alone, this drug trial is an important milestone in understanding a completely different treatment for depression.
Psychology. Neuroscience. Drugs. All can be tools of interrogation. In this episode, an expert shows me how to coerce unsuspecting subjects into signing false confessions; a police psychologist questions me about my personal life after I am injected with a truth serum; and I match wits against a new brainwave-reading lie-detection method developed at Northwestern University.
A plush country house is fixed with surveillance cameras while a group of unwitting test subjects are first exposed to youthful memories to test if it can improve their health. Dr Mosley takes them on this nostalgia trip with the help of neuroscientist Dr Jack Lewis and psychologist Anna Machin to determine how reliable memories really are.
Through interviews with leading psychologists and scientists, Neurons to Nirvana explores the history of four powerful psychedelic substances (LSD, Psilocybin, MDMA and Ayahuasca) and their previously established medicinal potential. Strictly focusing on the science and medicinal properties of these drugs, Neurons to Nirvana looks into why our society has created such a social and political bias against even allowing research to continue the exploration of any possible positive effects they can present in treating some of today's most challenging afflictions.
2013 • Brain